LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 81

Search options

  1. Article: Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia.

    Nashatyreva, Maria S / Trofimenko, Irina N / Chernyak, Boris A / Avdeev, Sergey N

    Life (Basel, Switzerland)

    2023  Volume 13, Issue 1

    Abstract: ... in the Irkutsk region (eastern Siberia). Each case of ILD (n = 270) was reviewed by a multidisciplinary ...

    Abstract Interstitial lung diseases (ILD) are part of a large heterogeneous group of diseases that differ in many ways (in their cause, clinical presentation, and response to therapy, etc.), but there are similar pathophysiological mechanisms involved in the development of the inflammation and/or fibrosis of the lungs. Currently, several criteria for pulmonary fibrosis (PF) and progressive pulmonary fibrosis (PPF) are proposed, and the information on the prevalence and characteristics of these conditions is limited. The aim of this study was to evaluate the spectrum of PF and PPF according to the registry of patients with ILD in eastern Siberia. Materials and methods: The study included patients with ILD from all of the medical institutions in the Irkutsk region (eastern Siberia). Each case of ILD (n = 270) was reviewed by a multidisciplinary discussion panel. The ILD patient registry included information on the clinical findings, history, pulmonary function tests, high-resolution computed tomography (HRCT), and histological findings. The follow-up period for the patients varied from 1 to 5 years. Results: Pulmonary fibrosis was detected by HRCT in 104 patients with ILD (38.5%). PF was present in 100% of the patients with IPF and SS-ILD, in 90.9% of the patients with CHP, in 71.4% of the patients with NSIP, and in 60% of the patients with RA-ILD. Sixty-two patients met the criteria for PPF (23.0% of the entire ILD cohort and 59.6% of the patients with PF). PPF occurred most often in the patients with IPF, CHP, IPAF, and SSc-ILD: 100%, 72.7%, 40%, and 38.5% of them, respectively. The variables associated with fibrosis progression included Velcro crackles (OR 18.3, p < 0.001) and late diagnosis (OR 4.1, p < 0.001). Conclusion: Pulmonary fibrosis and progressive pulmonary fibrosis are common in patients with ILD. The high mortality rate of PPF dictates the need for the active, early detection of a progressive fibrosing course of a wide range of ILD and suggests that further studies assessing the effectiveness of the interventions might be warranted.
    Language English
    Publishing date 2023-01-11
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662250-6
    ISSN 2075-1729
    ISSN 2075-1729
    DOI 10.3390/life13010212
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: High‑flow nasal cannula is not more effective than conventional oxygen therapy for acute exacerbation of COPD with mild hypercapnia: we are not sure.

    Avdeev, Sergey N / Yaroshetskiy, Andrey I / Nuralieva, Galia S / Avdeev, Ivan S / Shmidt, Anna E

    Critical care (London, England)

    2022  Volume 26, Issue 1, Page(s) 156

    MeSH term(s) Cannula ; Humans ; Hypercapnia/therapy ; Oxygen ; Oxygen Inhalation Therapy ; Pulmonary Disease, Chronic Obstructive/therapy
    Chemical Substances Oxygen (S88TT14065)
    Language English
    Publishing date 2022-05-31
    Publishing country England
    Document type Letter
    ZDB-ID 2041406-7
    ISSN 1466-609X ; 1364-8535
    ISSN (online) 1466-609X
    ISSN 1364-8535
    DOI 10.1186/s13054-022-04022-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Higher PEEP in intubated COVID-19-associated ARDS patients? We are not sure.

    Yaroshetskiy, Andrey I / Avdeev, Sergey N / Krasnoshchekova, Anna P / Nuralieva, Galia S

    Critical care (London, England)

    2022  Volume 26, Issue 1, Page(s) 327

    MeSH term(s) Humans ; COVID-19 ; Respiration, Artificial ; Positive-Pressure Respiration ; Respiratory Distress Syndrome/therapy
    Language English
    Publishing date 2022-10-25
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 2041406-7
    ISSN 1466-609X ; 1364-8535
    ISSN (online) 1466-609X
    ISSN 1364-8535
    DOI 10.1186/s13054-022-04207-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Asthma in elderly and coronavirus disease 2019: Results of 90-day post-hospital follow-up.

    Avdeev, Sergey N / Gaynitdinova, Viliya V / Pozdnakova, Anna A / Yu Chikina, Svetlana / Kosobokova, Karina A

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

    2023  Volume 131, Issue 5, Page(s) 663–664

    MeSH term(s) Humans ; Aged ; COVID-19 ; Follow-Up Studies ; Asthma/epidemiology ; Age Factors ; Hospitals
    Language English
    Publishing date 2023-08-07
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1228189-x
    ISSN 1534-4436 ; 0003-4738 ; 1081-1206
    ISSN (online) 1534-4436
    ISSN 0003-4738 ; 1081-1206
    DOI 10.1016/j.anai.2023.08.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Can We Reliably Predict the Failure of Noninvasive Ventilation in COVID-19-associated Acute Hypoxemic Respiratory Failure?

    Avdeev, Sergey N / Yaroshetskiy, Andrey I / Nuralieva, Galia S

    Annals of the American Thoracic Society

    2021  Volume 18, Issue 9, Page(s) 1595

    MeSH term(s) COVID-19 ; Humans ; Hypoxia/etiology ; Hypoxia/therapy ; Noninvasive Ventilation ; Respiratory Insufficiency/etiology ; Respiratory Insufficiency/therapy ; SARS-CoV-2
    Language English
    Publishing date 2021-05-25
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2717461-X
    ISSN 2325-6621 ; 1943-5665 ; 2325-6621
    ISSN (online) 2325-6621 ; 1943-5665
    ISSN 2325-6621
    DOI 10.1513/AnnalsATS.202101-047LE
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Comparative effectiveness of pneumococcal vaccination with PPV23 and PCV13 in COPD patients over a 5-year follow-up cohort study.

    Ignatova, Galina L / Avdeev, Sergey N / Antonov, Vladimir N

    Scientific reports

    2021  Volume 11, Issue 1, Page(s) 15948

    Abstract: ... years: PCV13 group (n = 123); PPV23 group (n = 32); and vaccine-naïve group (n = 147). The primary ...

    Abstract Vaccination against Streptococcus pneumoniae is among the most effective measures for preventing pneumonia and reducing the rate of chronic obstructive pulmonary disease (COPD) exacerbations. The objective of this work was to evaluate the long-term effectiveness of PCV13 and PPV23 for preventing pneumonia and COPD exacerbations. The open-label, prospective, observational cohort study involved 302 male patients aged ≥ 45 years: PCV13 group (n = 123); PPV23 group (n = 32); and vaccine-naïve group (n = 147). The primary endpoint included the frequency of pneumonia episodes and COPD exacerbations per year over a 5-year follow-up period. The secondary endpoints included the dynamics of dyspnea severity (MMRC), the BODE index, FEV1, the CAT index, the SGRQ score, and the results of 6-min walk test. Vaccination with PCV13 and PPV23 significantly reduces the total rate of pneumonia during the first year after vaccination. Starting with the second year, clinical effectiveness in PPV23 group decreases compared with both PCV13 group and vaccine-naïve patients. Pneumonia by year 5 after vaccination was registered in 47% of patients in the PPV23 group, versus 3.3% of patients in the PCV13 group (p < 0.001); COPD exacerbations-in 81.3% versus 23.6%, respectively (p < 0.001). Vaccination with PCV13 significantly reduced and maintained the BODE index over the 5-year follow-up period. Although both vaccines have comparable clinical effects during the first year after vaccination, only PCV13 is characterized by persistent clinical effectiveness during the 5-year follow-up period. Patients older than 55 years who received PPV23 have significantly higher risks of having pneumonia episodes more frequently during the long-term follow-up.
    MeSH term(s) Aged ; Aged, 80 and over ; Cohort Studies ; Cost-Benefit Analysis ; Follow-Up Studies ; Humans ; Immunization Programs ; Male ; Middle Aged ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines/genetics ; Pneumococcal Vaccines/immunology ; Pneumococcal Vaccines/therapeutic use ; Prospective Studies ; Pulmonary Disease, Chronic Obstructive/complications ; Pulmonary Disease, Chronic Obstructive/microbiology ; Russia/epidemiology ; Streptococcus pneumoniae/immunology ; Streptococcus pneumoniae/pathogenicity ; Vaccination/methods ; Vaccines, Conjugate/immunology
    Chemical Substances Pneumococcal Vaccines ; Vaccines, Conjugate
    Language English
    Publishing date 2021-08-05
    Publishing country England
    Document type Comparative Study ; Journal Article
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-021-95129-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally.

    Gredic, Marija / Karnati, Srikanth / Ruppert, Clemens / Guenther, Andreas / Avdeev, Sergey N / Kosanovic, Djuro

    Cells

    2023  Volume 12, Issue 9

    Abstract: Combined pulmonary fibrosis and emphysema (CPFE) is a recently recognized syndrome that, as its name indicates, involves the existence of both interstitial lung fibrosis and emphysema in one individual, and is often accompanied by pulmonary hypertension. ...

    Abstract Combined pulmonary fibrosis and emphysema (CPFE) is a recently recognized syndrome that, as its name indicates, involves the existence of both interstitial lung fibrosis and emphysema in one individual, and is often accompanied by pulmonary hypertension. This debilitating, progressive condition is most often encountered in males with an extensive smoking history, and is presented by dyspnea, preserved lung volumes, and contrastingly impaired gas exchange capacity. The diagnosis of the disease is based on computed tomography imaging, demonstrating the coexistence of emphysema and interstitial fibrosis in the lungs, which might be of various types and extents, in different areas of the lung and several relative positions to each other. CPFE bears high mortality and to date, specific and efficient treatment options do not exist. In this review, we will summarize current knowledge about the clinical attributes and manifestations of CPFE. Moreover, we will focus on pathophysiological and pathohistological lung phenomena and suspected etiological factors of this disease. Finally, since there is a paucity of preclinical research performed for this particular lung pathology, we will review existing animal studies and provide suggestions for the development of additional in vivo models of CPFE syndrome.
    MeSH term(s) Male ; Humans ; Pulmonary Fibrosis/complications ; Pulmonary Fibrosis/pathology ; Pulmonary Emphysema/diagnostic imaging ; Pulmonary Emphysema/complications ; Pulmonary Emphysema/pathology ; Lung/pathology ; Hypertension, Pulmonary ; Emphysema/complications
    Language English
    Publishing date 2023-04-28
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2661518-6
    ISSN 2073-4409 ; 2073-4409
    ISSN (online) 2073-4409
    ISSN 2073-4409
    DOI 10.3390/cells12091278
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Acute Respiratory Distress Syndrome in COVID-19: Do All These Patients Definitely Require Intubation and Mechanical Ventilation?

    Yaroshetskiy, Andrey I / Avdeev, Sergey N / Konanykhin, Vasily D

    American journal of respiratory and critical care medicine

    2020  Volume 202, Issue 10, Page(s) 1480–1481

    MeSH term(s) Betacoronavirus ; COVID-19 ; Cohort Studies ; Coronavirus Infections ; Humans ; Intubation, Intratracheal ; Pandemics ; Pneumonia, Viral ; Respiration, Artificial/adverse effects ; Respiratory Distress Syndrome/therapy ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-08-18
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 1180953-x
    ISSN 1535-4970 ; 0003-0805 ; 1073-449X
    ISSN (online) 1535-4970
    ISSN 0003-0805 ; 1073-449X
    DOI 10.1164/rccm.202007-2713LE
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Noninvasive ventilation in hospitalized patients with chronic obstructive pulmonary disease

    Sergey N. Avdeev

    Bûlleten' Sibirskoj Mediciny, Vol 16, Iss 2, Pp 6-

    2017  Volume 19

    Abstract: The use of noninvasive ventilation (NIV) of lungs during the last two decades significantly improved the results of management of severe COPD patients with acute or chronic respiratory failure during both periods of exacerbation and stability. At present, ...

    Abstract The use of noninvasive ventilation (NIV) of lungs during the last two decades significantly improved the results of management of severe COPD patients with acute or chronic respiratory failure during both periods of exacerbation and stability. At present, NIV is considered to be the first-line therapy for acute exacerbation of COPD with hypercapnia and respiratory acidosis. This method of airway support turned out to be effective in patients after extubation both for the relief of excommunication from a respirator and for prophylaxis and treatment of postextubation respiratory failure. NIV was proven to be successful in patients with a combination of COPD and obstructive sleep apnea (overlap syndrome), in COPD with pneumonia and in postoperative COPD patients who have undergone lung resectional surgery. The efficacy of NIV under intensive care and intensive therapy unit conditions has stimulated the interest to the use of mask ventilation in hospitals and out-patient departments (for a prolonged domestic therapy). This article presents a review of NIV use in patients with COPD during both periods of exacerbation and stability.
    Keywords copd ; noninvasive ventilation ; acute respiratory failure ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2017-07-01T00:00:00Z
    Publisher Siberian State Medical University (Tomsk)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: N-acetylcysteine for the treatment of COVID-19 among hospitalized patients.

    Avdeev, Sergey N / Gaynitdinova, Viliya V / Merzhoeva, Zamira M / Berikkhanov, Zelimkhan G-M

    The Journal of infection

    2021  Volume 84, Issue 1, Page(s) 94–118

    MeSH term(s) Acetylcysteine ; COVID-19 ; Humans ; Hydrogen Sulfide ; SARS-CoV-2
    Chemical Substances Acetylcysteine (WYQ7N0BPYC) ; Hydrogen Sulfide (YY9FVM7NSN)
    Language English
    Publishing date 2021-07-10
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 424417-5
    ISSN 1532-2742 ; 0163-4453
    ISSN (online) 1532-2742
    ISSN 0163-4453
    DOI 10.1016/j.jinf.2021.07.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top